"Benserazide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.
| Descriptor ID |
D001545
|
| MeSH Number(s) |
D02.442.175
|
| Concept/Terms |
Benserazide- Benserazide
- Seryltrihydroxybenzylhydrazine
- Seryltrihydroxy Benzylhydrazine
- Benzylhydrazine, Seryltrihydroxy
- DL-Serine 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide
- Serazide
|
Below are MeSH descriptors whose meaning is more general than "Benserazide".
Below are MeSH descriptors whose meaning is more specific than "Benserazide".
This graph shows the total number of publications written about "Benserazide" by people in this website by year, and whether "Benserazide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 3 | 3 |
| 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Benserazide" by people in Profiles.
-
A multiparametric analysis of the synergistic impact of anti-Parkinson's drugs on the fibrillation of human serum albumin. Biochim Biophys Acta Proteins Proteom. 2019 03; 1867(3):275-285.
-
Degeneration of the corticofugal tract from the secondary motor area in a Parkinson's disease patient with limb-kinetic apraxia: A case report. Medicine (Baltimore). 2017 Dec; 96(50):e9195.
-
Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study. Neurology. 2017 Aug 01; 89(5):432-438.
-
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease. Exp Neurol. 2017 05; 291:1-7.